文献速递产科母胎医学

取决于是否合并前置胎盘的胎盘植入谱系疾病临床相关因素:系统综述与Meta分析

Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2022-09-07

该系统综述与Meta分析纳入7项研究、共3,342例胎盘植入谱系疾病妊娠,比较合并与未合并前置胎盘者的危险因素和母体结局。未合并前置胎盘者更多与体外受精、既往刮宫和子宫肌瘤剔除相关,较少与既往剖宫产相关,产前诊断率更低,但母体结局更好。

要点

  • 未合并前置胎盘的胎盘植入谱系疾病与体外受精(OR 3.11)、既往刮宫(OR 1.60)和子宫肌瘤剔除(OR 2.47)关联更明显。
  • 未合并前置胎盘者与既往剖宫产关联较低(OR 0.15),产前诊断可能性较低(OR 0.07)。
  • 未合并前置胎盘者红细胞输注、重症监护入住、子宫切除、非计划分娩及术中肠管或膀胱损伤率更低。

核心结论

  • 未合并前置胎盘的胎盘植入谱系疾病与体外受精、既往刮宫和子宫肌瘤剔除关联更明显,与既往剖宫产关联较低。
  • 未合并前置胎盘者产前诊断可能性较低,但母体结局较合并前置胎盘者更好。

研究设计与样本

  • 系统检索Medline、EMBASE、ClinicalTrials.gov和Web of Science自建库至2022年4月25日,无语言或日期限制。
  • 筛选1,122篇文章后纳入7项研究,共3,342例胎盘植入谱系疾病妊娠(未合并前置胎盘2,365例,合并前置胎盘977例)。
  • 采用随机效应模型合并均数差或比值比(OR)及相应95%CI,使用RevMan软件。

主要发现

  • 未合并前置胎盘者体外受精率更高(OR 3.11,95%CI 1.93-5.02,P<.001,I²=52.0%)。
  • 未合并前置胎盘者既往刮宫(OR 1.60,95%CI 1.15-2.22,P=.005,I²=0.0%)和子宫肌瘤剔除(OR 2.47,95%CI 1.31-4.66,P=.005,I²=0.0%)关联更高。
  • 未合并前置胎盘者既往剖宫产关联更低(OR 0.15,95%CI 0.06-0.37,P<.001,I²=87.0%)。
  • 未合并前置胎盘者产前诊断可能性更低(OR 0.07,95%CI 0.04-0.11,P<.001,I²=38.0%)。
  • 未合并前置胎盘者红细胞输注、重症监护入住、子宫切除、非计划分娩及术中肠管或膀胱损伤率更低。

关键数值与推荐

  • 纳入标准为比较合并与未合并前置胎盘的胎盘植入谱系疾病妊娠危险因素和母体结局的研究。
  • 未合并前置胎盘者体外受精OR 3.11(95%CI 1.93-5.02,P<.001,I²=52.0%)。
  • 未合并前置胎盘者既往刮宫OR 1.60(95%CI 1.15-2.22,P=.005,I²=0.0%),子宫肌瘤剔除OR 2.47(95%CI 1.31-4.66,P=.005,I²=0.0%)。
  • 未合并前置胎盘者既往剖宫产OR 0.15(95%CI 0.06-0.37,P<.001,I²=87.0%)。
  • 未合并前置胎盘者产前诊断OR 0.07(95%CI 0.04-0.11,P<.001,I²=38.0%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether there are differences in risk factors and maternal outcomes of pregnancies complicated by placenta accreta spectrum depending on the presence or absence of placenta previa. DATA SOURCES: We performed a systematic search in Medline, EMBASE, ClinicalTrials.gov , and Web of Science from inception through April 25, 2022, without language or date restrictions. Search strategy included the key words "placenta accreta," "placenta increta," "placenta percreta," "adherent placenta," "invasive placenta," "abnormal placent*," "placenta previa," and "marginal placent*." METHODS OF STUDY SELECTION: Of the 1,122 articles screened, seven studies were included in the final review. Studies were included if they compared the risk factors and maternal outcomes of pregnancies complicated by placenta accreta spectrum depending on the presence or absence of placenta previa. TABULATION, INTEGRATION, AND RESULTS: A random-effects model was used to pool the mean differences or odds ratios (OR) and the corresponding 95% CIs using RevMan software. A total of 3,342 pregnancies complicated by placenta accreta spectrum were included in the meta-analysis (2,365 without previa and 977 with previa). Pregnancies complicated by placenta accreta spectrum without previa were more likely to have been conceived by in vitro fertilization (IVF) (OR 3.11, 95% CI 1.93-5.02, P <.001, I 2 =52.0%) and to be associated with prior dilation and curettage (D&C) (OR 1.60, 95% CI 1.15-2.22, P =.005, I 2 =0.0%) and myomectomy (OR 2.47, 95% CI 1.31-4.66, P =.005, I 2 =0.0%), but they were less likely to be associated with prior cesarean delivery (OR 0.15, 95% CI 0.06-0.37, P <.001, I 2 =87.0%). Placenta accreta spectrum without previa was less likely to be diagnosed antenatally (OR 0.07, 95% CI 0.04-0.11, P <.001, I 2 =38.0%). Also, women with pregnancies without previa had lower rates of red blood cell transfusion, intensive care unit admission, risk of hysterectomy, unscheduled delivery, and intraoperative bowel or bladder injuries. CONCLUSION: Pregnancies complicated by placenta accreta spectrum without previa had a more prominent association with IVF and prior D&C and myomectomy but were much less likely to be associated with prior cesarean delivery. Further, placenta accreta spectrum without previa was less likely to be diagnosed antenatally, although it had better maternal outcomes as compared with placenta accreta spectrum with previa. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42022307637.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hessami K, Salmanian B, Einerson BD, et al. Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022. PMID: 36075058. doi:10.1097/AOG.0000000000004923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。